Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease

New England Journal of Medicine

Volumn 361, Issue 17, 2009, Pages 1651-1661

  Sidransky, Ellen ^a   Nalls, Michael A ^b   Aasly, Jan O ^c,d   Aharon Peretz, Judith ^e   Annesi, Grazia ^h   Barbosa, Egberto R ^j   Bar Shira, Anat ^k   Berg, Daniela ⁿ   Bras, Jose ^b,o   Brice, Alexis ^q,r   Chen, Chiung Mei ^s   Clark, Lorraine N ^t   Condroyer, Christel ^q   De Marco, Elvira V ^h   Dürr, Alexandra ^q,r   Eblan, Michael J ^a   Fahn, Stanley ^t   Farrer, Matthew J ^w   Fung, Hon Chung ^s   Gan Or, Ziv ^k,m   Gasser, Thomas ⁿ   Gershoni Baruch, Ruth ^f,g   Giladi, Nir ^l,m   Griffith, Alida ^x   Gurevich, Tanya ^l,m   Januario, Cristina ^p   Kropp, Peter ^y   Lang, Anthony E ^z   Lee Chen, Guey Jen ^ab   Lesage, Suzanne ^q   Marder, Karen ^t,u   Mata, Ignacio F ^ac,ad   Mirelman, Anat ^l   Mitsui, Jun ^ae   Mizuta, Ikuko ^af   Nicoletti, Giuseppe ^h,i   Oliveira, Catarina ^o,p   Ottman, Ruth ^t,u,v   Orr Urtreger, Avi ^k,m   Pereira, Lygia V ^j   Quattrone, Aldo ^h,i   Rogaeva, Ekaterina ^aa   Rolfs, Arndt ^y   Rosenbaum, Hanna ^g   Rozenberg, Roberto ^j   Samii, Ali ^b,z,aa   Samaddar, Ted ^a   Schulte, Claudia ⁿ   Sharma, Manu ^j,n   Singleton, Andrew ^b,ac,ad   Spitz, Mariana ^j,n   Tan, Eng King ^ag,ah   Tayebi, Nahid ^a   Toda, Tatsushi ^af   Troiano, André R ^q   Tsuji, Shoji ^ae   Wittstock, Matthias ^y   Wolfsberg, Tyra G ^a   Wu, Yih Ru ^s   Zabetian, Cyrus P ^ac,ad   Zhao, Yi ^ag   Ziegler, Shira G ^a   more..

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^e Rambam Health Care Campus   (Israel)

^f RAMBAM MEDICAL CENTER   (Israel)

^g TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^h INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

ⁱ UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^j UNIVERSITY OF SÃO PAULO   (Brazil)

^k Genetic Institute   (Israel)

^l TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^m TEL AVIV UNIVERSITY   (Israel)

ⁿ UNIVERSITY OF TÜBINGEN   (Germany)

^o UNIVERSITY OF COIMBRA   (Portugal)

^p UNIVERSITY OF COIMBRA   (Portugal)

^q INSERM   (France)

^r PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^s CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^t Chang Gung University College of Medicine ^*  (United States)

^u Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^v Columbia University ^*  (United States)

^w MAYO CLINIC   (United States)

^x Evergreen Hospital Medical Center   (United States)

^y UNIVERSITY OF ROSTOCK   (Germany)

^z TORONTO WESTERN HOSPITAL   (Canada)

^aa UNIVERSITY OF TORONTO   (Canada)

^ab NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

^ac VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^ad UNIVERSITY OF WASHINGTON   (United States)

^ae UNIVERSITY OF TOKYO   (Japan)

^af KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^ag SINGAPORE GENERAL HOSPITAL   (Singapore)

^ah DUKE NUS MEDICAL SCHOOL   (Singapore)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSYLCERAMIDASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 70350319531     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0901281     Document Type: Article

References (43)

1. Beutler E, Grabowski GA. Gaucher disease. In: Scriver CR, Beaudet AR, Sly W, Valle D, eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2001:3635-3668
2. Sidransky E. Gaucher disease: complexity in a "simple" disorder. Mol Genet Metab 2004;83:6-15.
3. Lwin A, Orvisky E, Goker-Alpan O, LaMarca ME, Sidransky E. Glucocerebrosidase mutations in subjects with parkinsonism. Mol Genet Metab 2004;81:70-73
4. Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med 2004;351:1972-1977 (Pubitemid 39447138)
5. Clark LN, Ross BM, Wang Y, et al. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology 2007;69:1270-1277 (Pubitemid 47429028)
6. Gan-Or Z, Giladi N, Rozovski U, et al. Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology 2008;70:2277-2283
7. Sato C, Morgan A, Lang AE, et al. Analysis of the glucocerebrosidase gene in Parkinson's disease. Mov Disord 2005;20:367-370 (Pubitemid 40613301)
8. Eblan MJ, Nguyen J, Ziegler SG, et al. Glucocerebrosidase mutations are also found in subjects with early-onset parkinsonism from Venezuela. Mov Disord 2006;21:282-283
9. Spitz M, Rozenberg R, Pereira Lda V, Reis Barbosa E. Association between Parkinson's disease and glucocerebrosidase mutations in Brazil. Parkinsonism Relat Disord 2008;14:58-62.
10. Bras J, Paisan-Ruiz C, Guerreiro R, et al. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal. Neurobiol Aging 2009;30:1515-1517
11. Mata IF, Samii A, Schneer SH, et al. Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. Arch Neurol 2008;65:379-382
12. Toft M, Pielsticker L, Ross OA, Aasly JO, Farrer MJ. Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population. Neurology 2006;66:415-417 (Pubitemid 43739947)
13. De Marco EV, Annesi G, Tarantino P, et al. Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy. Mov Disord 2008;23:460-463
14. Ziegler SG, Eblan MJ, Gutti U, et al. Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease. Mol Genet Metab 2007;91:195-200. (Pubitemid 46765177)
15. Wu YR, Chen CM, Chao CY, et al. Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese. J Neurol Neurosurg Psychiatry 2007;78:977-979
16. Tan EK, Tong J, Fook-Chong S, et al. Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients. Arch Neurol 2007;64:1056-1058 (Pubitemid 47048012)
17. Neumann J, Bras J, Deas E, et al. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain 2009;132:1783-1794
18. Nichols WC, Pankratz N, Marek DK, et al. Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset. Neurology 2009;72:310-316
19. Mitsui J, Mizuta I, Toyoda A, et al. Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol 2009;66:571-576
20. Kalinderi K, Bostantjopoulou S, Paisan-Ruiz C, Katsarou Z, Hardy J, Fidani L. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece. Neurosci Lett 2009;452:87-89
21. The PDGene Database. Alzheimer research forum, 2009. (Accessed September 25, 2009, at http://www.pdgene.org/.)
22. Machaczka M, Rucinska M, Skotnicki AB, Jurczak W. Parkinson's syndrome preceding clinical manifestation of Gaucher's disease. Am J Hematol 1999;61:216-217 (Pubitemid 29297895)
23. Tayebi N, Callahan M, Madike V, et al. Gaucher disease and parkinsonism: a phenotypic and genotypic characterization. Mol Genet Metab 2001;73:313-321 (Pubitemid 32846370)
24. Neudorfer O, Giladi N, Elstein D, et al. Occurrence of Parkinson's syndrome in type I Gaucher disease. QJM 1996;89:691-694 (Pubitemid 26319021)
25. Tayebi N, Walker J, Stubblefield B, et al. Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 2003;79:104-109
26. Goker-Alpan O, Lopez G, Vithayathil J, Davis J, Hallett M, Sidransky E. The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol 2008;65:1353-1357
27. Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E. Parkinsonism among Gaucher disease carriers. J Med Genet 2004;41:937-940
28. Halperin A, Elstein D, Zimran A. Increased incidence of Parkinson disease among relatives of patients with Gaucher disease. Blood Cells Mol Dis 2006;36:426-428 (Pubitemid 43776190)
29. Hruska KS, LaMarca ME, Scott CR, Sidransky E. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat 2008;29:567-583 (Pubitemid 351614580)
30. Montfort M, Chabás A, Vilageliu L, Grinberg D. Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: pathogenic changes and "modifier" polymorphisms. Hum Mutat 2004;23:567-575 [Erratum, Hum Mutat 2005;26:276.] (Pubitemid 38720608)
31. Winfield SL, Tayebi N, Martin BM, Ginns EI, Sidransky E. Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher disease. Genome Res 1997;7:1020-1026 (Pubitemid 27487766)
32. Tayebi N, Stubblefield BK, Park JK, et al. Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: implications for complexity in Gaucher disease. Am J Hum Genet 2003;72:519-534 (Pubitemid 36255951)
33. Wan L, Hsu CM, Tsai CH, Lee CC, Hwu WL, Tsai FJ. Mutation analysis of Gaucher disease patients in Taiwan: high prevalence of the RecNciI and L444P mutations. Blood Cells Mol Dis 2006;36:422-425 (Pubitemid 43776181)
34. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752
35. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955;19:251-253
36. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2005. (Accessed September 25, 2009, at http://www.R-project.org.)
37. Park JK, Tayebi N, Stubblefield BK, et al. The E326K mutation and Gaucher disease: mutation or polymorphism? Clin Genet 2002;61:32-34
38. Goker-Alpan O, Giasson BI, Eblan MJ, et al. Glucocerebrosidase mutations are an important risk factor for Lewy body disorders. Neurology 2006;67:908-910 (Pubitemid 44394221)
39. Clark LN, Kartsaklis LA, Wolf Gilbert R, et al. Association of glucocerebrosidase mutations with dementia with Lewy bodies. Arch Neurol 2009;66:578-583
40. Farrer MJ, Williams LN, Algom AA, et al. Glucosidase-beta variations and Lewy body disorders. Parkinsonism Relat Disord 2009;15:414-416
41. Segarane B, Li A, Paudel R, et al. Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology 2009;72:1185-1186
42. DePaolo J, Goker-Alpan O, Samaddar T, Lopez G, Sidransky E. The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism. Mov Disord 2009 May 7 (Epub ahead of print).
43. Bras J, Singleton A, Cookson MR, Hardy J. Emerging pathways in genetic Parkinson's disease: potential role of ceramide metabolism in Lewy body disease. FEBS J 2008;275:5767-5773